Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Histone Deacetylase Inhibitors Research

13 та иш

  1. Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

    Yang He, Yuefei Fang, Meng Zhang +7

    МақолаHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B20214 иқтибос
    ABI

  2. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

    Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

    МақолаProtein Degradation and InhibitorsBiomolecules20262 иқтибос
    ABI

  3. Demethyldihydroglycyrin tetraacetate

    Shakhnoza S. Azimova, Валентина И. Виноградова

    БобHyperglycemia and glycemic control in critically ill and hospitalized patients20120 иқтибос
    ABI

  4. 28-epi-Isocyasterone

    Shakhnoza S. Azimova

    БобOrganic Chemistry Cycloaddition Reactions20120 иқтибос
    ABI

  5. Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer

    Yonghui Wang, Binfan Chen, Zhidi He +7

    МақолаHistone Deacetylase Inhibitors ResearchNanoscale20210 иқтибос
    ABI

  6. The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats

    D. Tursunov, Rixsi A. Sabirova, М. У. Кульманова +5

    МақолаProtease and Inhibitor MechanismsBioNanoScience20210 иқтибос
    ABI

  7. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

    Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali +6

    МақолаColorectal Cancer Treatments and StudiesCell Biochemistry and Function20240 иқтибос
    ABI

  8. Ubiquitylation in the development of somatic diseases: a mechanism of cellular regulation and a new therapeutic target

    Александр Ураков, Anton Tyurin, V. S. Shchekin +4

    МақолаUbiquitin and proteasome pathwaysReviews on Clinical Pharmacology and Drug Therapy20240 иқтибос
    ABI

  9. AML-489: Combination of Azacitidine and Venetoclax in Patients With Acute Myeloid Leukemia: A Single-Center Experience

    Farhodjon Tashtemirov, Z.V. Yunusova, M Islamov +3

    МақолаAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia20250 иқтибос
    ABI

  10. Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds

    Mohammed H. Mohammed, Raed Fanoukh Aboqader Al-Aouadi, Subasini Uthirapathy +7

    Шарҳ мақолаHistone Deacetylase Inhibitors ResearchNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
    ABI

  11. Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications

    Hussein Salim Abed, N. Esanmurodova, Abhinav Kumar +6

    Шарҳ мақолаEpigenetics and DNA MethylationNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
    ABI

  12. Epigenetic clocks and biological aging acceleration in early-onset hypertension

    Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3

    МақолаEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  13. Epigenetic clocks and biological aging acceleration in early-onset hypertension

    Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3

    МақолаEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI